50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow’s Guide in the Clinic
Cet article passe en revue les principaux points de ces 50 dernières années concernant les cancers du poumon (prévention, dépistage, diagnostic, stadification, traitements et soins de support)
The past 50 years have seen a dramatic evolution in thoracic oncology. We have gone from a time of limited understanding of the biology of lung cancer, no demonstrated benefits for screening, and marginal benefits from therapy to an era of molecular profiling, survival benefits from low-dose CT screening, and a steadily expanding list of therapeutic options...
Journal of Thoracic Oncology , résumé, 2025